Published in Am J Pathol on February 01, 2004
How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol (2010) 2.11
Immune surveillance by the liver. Nat Immunol (2013) 1.79
Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol (2009) 1.39
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol (2009) 1.37
Immune interactions in hepatic fibrosis. Clin Liver Dis (2008) 1.23
Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol (2010) 1.22
Liver antigen-presenting cells. J Hepatol (2010) 1.22
Innate immune cells in liver inflammation. Mediators Inflamm (2012) 1.11
NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol (2009) 0.99
Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol (2005) 0.93
Regulation of NK cell repertoire and function in the liver. Crit Rev Immunol (2011) 0.93
Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol (2016) 0.88
Dissecting the dendritic cell controversy in chronic hepatitis B virus infection. Cell Mol Immunol (2014) 0.87
Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B. Antimicrob Agents Chemother (2005) 0.82
An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci (2013) 0.81
The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis. Clin Dev Immunol (2010) 0.81
Tissue-resident dendritic cells and diseases involving dendritic cell malfunction. Int Immunopharmacol (2016) 0.80
Dendritic cells and liver fibrosis. Biochim Biophys Acta (2013) 0.79
Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment. PLoS Negl Trop Dis (2010) 0.78
Ontogeny and phagocytic function of baboon lung dendritic cells. Immunol Cell Biol (2009) 0.77
Immune-Mediated Therapies for Liver Cancer. Genes (Basel) (2017) 0.75
Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease. Gut (2005) 0.75
MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression. PLoS One (2015) 0.75
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol (2002) 10.15
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature (2003) 7.56
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 5.17
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol (2001) 5.11
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med (1990) 4.48
Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med (1999) 3.79
Hepatic T cells and liver tolerance. Nat Rev Immunol (2003) 3.51
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol (1995) 3.39
CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity (2000) 3.27
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J Exp Med (1982) 3.11
Local control of the immune response in the liver. Immunol Rev (2000) 3.01
Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol (2001) 2.89
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol (1998) 2.32
The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol (1998) 2.27
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.14
Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol (2001) 1.74
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med (1996) 1.63
Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity (2003) 1.58
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med (1999) 1.39
CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur J Immunol (1995) 1.34
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol (2001) 1.16
Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16
Biosynthesis and posttranslational regulation of human IL-12. J Immunol (2000) 1.09
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol (2001) 1.08
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood (2002) 1.05
Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation (2001) 1.01
Isolation of human blood dendritic cells by discontinuous Nycodenz gradient centrifugation. J Immunol Methods (1995) 0.92
Isolation and characterization of migratory human skin dendritic cells. Clin Exp Immunol (1994) 0.89
Flexibility and cooperation among dendritic cells. Nat Immunol (2000) 0.81
Prolongation of rat renal allograft survival by portal venous inoculation with donor lymphocytes. Transplant Proc (1989) 0.77
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science (2006) 5.31
Aortic valve surgery after previous coronary artery bypass grafting with functioning internal mammary artery grafts. Ann Thorac Surg (2002) 2.88
Results and predictors of early and late outcomes of coronary artery bypass graft surgery in octogenarians. J Cardiothorac Vasc Anesth (2007) 2.73
Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology (2008) 2.43
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology (2010) 2.37
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med (2007) 2.32
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry (2006) 2.28
Integrated thoracic residency program applicants: the best and the brightest? Ann Thorac Surg (2011) 2.22
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A (2010) 2.19
Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1 526 360 coronary bypass operations. Heart (2013) 2.15
The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease. Gastroenterology (2002) 2.12
Management of systolic anterior motion after mitral valve repair: an algorithm. J Thorac Cardiovasc Surg (2012) 2.07
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
Cardiac myxoma: preoperative diagnosis using a multimodal imaging approach and surgical outcome in a large contemporary series. Interact Cardiovasc Thorac Surg (2007) 2.03
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J Hepatol (2012) 1.95
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology (2010) 1.82
Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation (2009) 1.78
A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J (2010) 1.78
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. Ann Thorac Surg (2006) 1.75
The intraoperative "ink test": a novel assessment tool in mitral valve repair. J Thorac Cardiovasc Surg (2007) 1.64
Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol (2010) 1.61
Incidence, topography, predictors and long-term survival after stroke in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2008) 1.60
Primary sclerosing cholangitis. Lancet (2013) 1.59
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med (2005) 1.57
Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol (2002) 1.55
Inverted left atrial appendage. J Am Coll Cardiol (2009) 1.55
Predictors and early and late outcomes of dialysis-dependent patients in contemporary cardiac surgery. J Cardiothorac Vasc Anesth (2008) 1.54
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry (2009) 1.53
CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol (2005) 1.49
Recruitment of lymphocytes to the human liver. Immunol Cell Biol (2002) 1.49
Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication. Hepatology (2013) 1.47
Tracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Ann Thorac Surg (2007) 1.46
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology (2009) 1.46
Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology (2009) 1.46
Predictors and outcomes of seizures after cardiac surgery: a multivariable analysis of 2,578 patients. Ann Thorac Surg (2011) 1.45
Liberal use of delayed sternal closure for postcardiotomy hemodynamic instability. Ann Thorac Surg (2002) 1.45
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol (2015) 1.43
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med (2004) 1.43
Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation. Ann Thorac Surg (2011) 1.42
Does prior coronary bypass surgery present a unique risk for reoperative valve surgery? Ann Thorac Surg (2013) 1.41
[Remodeling annuloplasty using a prosthetic ring designed for correcting type-IIIb ischemic mitral regurgitation]. Rev Esp Cardiol (2007) 1.41
Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol (2006) 1.40
Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology (2008) 1.39
Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth (2009) 1.38
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology (2005) 1.37
Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery. Ann Surg (2007) 1.35
Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One (2011) 1.34
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med (2012) 1.32
Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg (2005) 1.31
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30
CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol (2005) 1.30
Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterology (2009) 1.29
An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine. J Physiol (2008) 1.29
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg (2008) 1.26
Mitral valve repair with Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring for ischemic mitral regurgitation: early echocardiographic results from a multi-center study. Circulation (2006) 1.24
Immune interactions in hepatic fibrosis. Clin Liver Dis (2008) 1.23
Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transpl (2010) 1.23
Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am J Pathol (2011) 1.21
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 1.20
Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol (2002) 1.19
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg (2012) 1.18
The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis (2007) 1.18
Seeking a higher standard for degenerative mitral valve repair: begin with etiology. J Thorac Cardiovasc Surg (2008) 1.16
The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun (2009) 1.14
Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg (2007) 1.13
Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet (2002) 1.13
Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg (2012) 1.13
Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. J Immunol (2011) 1.13
Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology (2012) 1.12
The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol (2004) 1.12
Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg (2013) 1.11
T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6. Eur Urol (2011) 1.10
Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg (2007) 1.09
Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting. J Heart Valve Dis (2002) 1.08
Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress. Autophagy (2012) 1.08
Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08
Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol (2009) 1.07
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. J Clin Psychopharmacol (2006) 1.06
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology (2014) 1.06
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood (2008) 1.05
Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest (2008) 1.05
Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol (2008) 1.05
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int (2010) 1.05
CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium. Hepatology (2010) 1.05
Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol (2006) 1.04
The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis (2010) 1.04
Mitral valve hemodynamics after repair of acute posterior leaflet prolapse: quadrangular resection versus triangular resection versus neochordoplasty. J Thorac Cardiovasc Surg (2009) 1.04
Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding. Virology (2008) 1.04
GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease. IDrugs (2010) 1.03
Incidence, imaging analysis, and early and late outcomes of stroke after cardiac valve operation. Am J Cardiol (2008) 1.03
Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity. Hepatology (2011) 1.02
CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2. Cell Signal (2005) 1.02
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. J Clin Psychopharmacol (2008) 1.02
Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure. Nephrol Dial Transplant (2008) 1.01
Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology (2007) 1.01